Lucie Biard

6PUBLICATIONS
13CO-AUTHORS
Radiation therapyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 16, 2026
Are safety lead-in phase II clinical trials really safe?

|Nov 20, 2023
Drug combinations screening using a Bayesian ranking approach based on dose-response models.

Luana Boumendil, Morgane Fontaine, Vincent Lévy

|Oct 19, 2022
Surv-CRM-12: A Bayesian phase I/II survival CRM for right-censored toxicity endpoints with competing disease progression.

Anaïs Andrillon, Sylvie Chevret, Shing M Lee

|Mar 31, 2022
Cerebrovascular Ischemic Events in Patients With Takayasu Arteritis.

Adrien Mirouse, Sandrine Deltour, Delphine Leclercq

|Nov 03, 2021
DICE: A Bayesian model for early dose finding in phase I trials with multiple treatment courses.

Moreno Ursino, Lucie Biard, Sylvie Chevret

|Jul 02, 2021
Seamless phase I/II design for novel anticancer agents with competing disease progression.

Lucie Biard, Shing M Lee, Bin Cheng

Pageof 1

Frequent Collaborators

3 joint publications

Shing M Lee

1 joint publications

Bin Cheng

1 joint publications

Moreno Ursino

1 joint publications

Adrien Mirouse